Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Inotrem closes €18mm Series A round to support sepsis candidate

28 Mar 2014

Executive Summary

In the largest European Series A financing so far this year, French biotech Inotrem SA closed an €18mm ($25mm) first round led by Edmond de Rothschild Investment Partners and Sofinnova Partners, which each add a board member and were joined by Biomed Invest and Inserm Transfert Initiative.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By